Mental Health and Disease Nursing Thesis Master's Degree
Course Details
KTO KARATAY UNIVERSITY
Graduate Education Institute
Programme of Mental Health and Disease Nursing Thesis Master's Degree
Course Details
Graduate Education Institute
Programme of Mental Health and Disease Nursing Thesis Master's Degree
Course Details
| Course Code | Course Name | Year | Period | Semester | T+A+L | Credit | ECTS |
|---|---|---|---|---|---|---|---|
| 82411110 | Advanced Psychopharmacology | 1 | Autumn | 1 | 3+0+0 | 7,5 | 7,5 |
| Course Type | Elective |
| Course Cycle | Master's (Second Cycle) (TQF-HE: Level 7 / QF-EHEA: Level 2 / EQF-LLL: Level 7) |
| Course Language | Turkish |
| Methods and Techniques | - |
| Mode of Delivery | Face to Face |
| Prerequisites | - |
| Coordinator | - |
| Instructor(s) | Asst. Prof. Bahriye HORASANLI |
| Instructor Assistant(s) | - |
Course Instructor(s)
| Name and Surname | Room | E-Mail Address | Internal | Meeting Hours |
|---|---|---|---|---|
| Asst. Prof. Bahriye HORASANLI | - | [email protected] |
Course Content
The content of the course is based on the definition of psychopharmacology, its functioning and the areas of use of drugs, and the effects of psychopharmacological agents used in their developmental stages.
Objectives of the Course
This course has been prepared to give theoretical information about the definition and functioning of psychopharmacology, the mechanisms of action of drugs used in the field, and their areas of use.
Contribution of the Course to Field Teaching
| Basic Vocational Courses | X |
| Specialization / Field Courses | X |
| Support Courses | |
| Transferable Skills Courses | |
| Humanities, Communication and Management Skills Courses |
Relationships between Course Learning Outcomes and Program Outcomes
| Relationship Levels | ||||
| Lowest | Low | Medium | High | Highest |
| 1 | 2 | 3 | 4 | 5 |
| # | Program Learning Outcomes | Level |
|---|---|---|
| P2 | Have advanced nursing skills in the management of mental disorders, crisis intervention, therapeutic communication and rehabilitation processes. | 5 |
Course Learning Outcomes
| Upon the successful completion of this course, students will be able to: | |||
|---|---|---|---|
| No | Learning Outcomes | Outcome Relationship | Measurement Method ** |
| O1 | Can explain the basic concepts, historical development and current approaches of psychopharmacology at an advanced level. | P.2.5 | 1 |
| O2 | Analyze in detail the functioning of neurotransmitter systems in the central nervous system, receptor types, and the psychopharmacological basis of synaptic transmission. | P.2.6 | 1 |
| O3 | Have an advanced understanding of pharmacokinetic processes (absorption, distribution, metabolism, excretion) and pharmacodynamic mechanisms (receptor binding, mechanisms of action, dose-response relationships). | P.2.7 | 1 |
| O4 | Explain in detail the mechanisms of action, indications, side effects, contraindications and drug interactions of antidepressant drugs. | P.2.8 | 1 |
| O5 | Analyze the pharmacological properties, usage areas, addiction potential and safe use principles of anxiolytic and sedative-hypnotic drugs. | P.2.9 | 1 |
| O6 | It can comprehensively evaluate the differences, mechanisms of action, metabolic side effects, extrapyramidal symptoms and tardive dyskinesia risk of first and second generation antipsychotic drugs. | P.2.10 | 1 |
| O7 | Explain the role of mood stabilizing medications in the treatment of bipolar disorder, therapeutic blood level monitoring, and signs of toxicity. | P.2.11 | 1 |
| O8 | Evaluate therapeutic use of stimulant medications, their side effects, and risks of abuse. | P.2.12 | 1 |
| O9 | Define the role and responsibilities of the nurse/psychologist/other health professionals in the psychopharmacological treatment process within the multidisciplinary team. | P.2.13 | 1 |
| ** Written Exam: 1, Oral Exam: 2, Homework: 3, Lab./Exam: 4, Seminar/Presentation: 5, Term Paper: 6, Application: 7 | |||
Weekly Detailed Course Contents
| Week | Topics |
|---|---|
| 1 | Introduction to Psychopharmacology |
| 2 | neurotransmitters |
| 3 | Psychopharmacology in Children and Adolescents |
| 4 | Geriatric Psychopharmacology |
| 5 | Tricyclic Antidepressants |
| 6 | SSRI's |
| 7 | Seratonergic Drugs(Other) |
| 8 | Anxiolytics |
| 9 | Typical Antipsychotics |
| 10 | 2nd generation and later antipsychotics |
| 11 | Mood Stabilizers |
| 12 | Stimulants |
| 13 | Drugs used to treat dementia |
| 14 | General Exam |
Textbook or Material
| Resources | Yüksel, N. (2007). Psikofarmakoloji. Medikal Network Nobel Kitabevi. |
Evaluation Method and Passing Criteria
| In-Term Studies | Quantity | Percentage |
|---|---|---|
| Attendance | - | - |
| Field Study | - | - |
| Course Specific Internship (If Any) | - | - |
| Homework | - | - |
| Presentation | - | - |
| Seminar | - | - |
| Quiz | - | - |
| Listening | - | - |
| Midterms | 1 | 30 (%) |
| Final Exam | 1 | 70 (%) |
| Total | 100 (%) | |
ECTS / Working Load Table
| Quantity | Duration | Total Work Load | |
|---|---|---|---|
| Course Week Number and Time | 14 | 3 | 42 |
| Out-of-Class Study Time (Pre-study, Library, Reinforcement) | 14 | 4 | 56 |
| Midterms | 1 | 2 | 2 |
| Quiz | 0 | 0 | 0 |
| Homework | 8 | 4 | 32 |
| Practice | 0 | 0 | 0 |
| Laboratory | 0 | 0 | 0 |
| Project | 0 | 0 | 0 |
| Workshop | 0 | 0 | 0 |
| Presentation/Seminar Preparation | 14 | 6 | 84 |
| Fieldwork | 0 | 0 | 0 |
| Final Exam | 1 | 2 | 2 |
| Other | 0 | 0 | 0 |
| Total Work Load: | 218 | ||
| Total Work Load / 30 | 7,27 | ||
| Course ECTS Credits: | 7 | ||
Course - Learning Outcomes Matrix
| Relationship Levels | ||||
| Lowest | Low | Medium | High | Highest |
| 1 | 2 | 3 | 4 | 5 |
| # | Learning Outcomes | P2 |
|---|---|---|
| O1 | Can explain the basic concepts, historical development and current approaches of psychopharmacology at an advanced level. | 5 |
| O2 | Analyze in detail the functioning of neurotransmitter systems in the central nervous system, receptor types, and the psychopharmacological basis of synaptic transmission. | 5 |
| O3 | Have an advanced understanding of pharmacokinetic processes (absorption, distribution, metabolism, excretion) and pharmacodynamic mechanisms (receptor binding, mechanisms of action, dose-response relationships). | 5 |
| O4 | Explain in detail the mechanisms of action, indications, side effects, contraindications and drug interactions of antidepressant drugs. | 5 |
| O5 | Analyze the pharmacological properties, usage areas, addiction potential and safe use principles of anxiolytic and sedative-hypnotic drugs. | 5 |
| O6 | It can comprehensively evaluate the differences, mechanisms of action, metabolic side effects, extrapyramidal symptoms and tardive dyskinesia risk of first and second generation antipsychotic drugs. | 5 |
| O7 | Explain the role of mood stabilizing medications in the treatment of bipolar disorder, therapeutic blood level monitoring, and signs of toxicity. | 5 |
| O8 | Evaluate therapeutic use of stimulant medications, their side effects, and risks of abuse. | 5 |
| O9 | Define the role and responsibilities of the nurse/psychologist/other health professionals in the psychopharmacological treatment process within the multidisciplinary team. | 5 |